Answers are grounded in this paper and cite their sources.
There is considerable controversy over the level of evidence from randomized trials underpinning management decisions for patients presenting with localized cancer of the esophagus and esophago-gastric junction. There is also an optimism that new drugs and new approaches, including response prediction based on sequential (18)FDG-PET scanning following induction chemotherapy, may improve treatments pathways and outcomes. In this review we assess the level of evidence from the major published trials, and discuss new trials and approaches.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: